Jeffrey S. Cohen

A federal jury in Boston, Massachusetts returned a verdict in favor of CardiAQ in a lawsuit filed against Neovasc Inc (US) (NASDAQ: NVCN). Ladenburg Thalmann’s Jeffrey S. Cohen downgraded the rating for the company from Buy to Neutral, while removing the price target. The jury found in...